From localized to metastatic #ProstateCancer, where can AI-based biomarkers help inform care?

This @Medscape feature explores the growing clinical evidence behind #ArteraAI across the prostate cancer care continuum and beyond.

Read more: buff.ly/QZPlToC

In case you missed it: research showing that multimodal AI predicts abiraterone benefit in very high-risk #ProstateCancer is heading to print in the October issue of Annals of Oncology.

Read the full publication: buff.ly/zkVMcnp

#ArteraAI

In our latest blog, Brad Macdonald goes behind the scenes of the data infrastructure Artera built to prepare thousands of gigapixel-scale pathology images for model development.

Read more: buff.ly/beVrNpP

#ArteraAI

As pathology AI moves into clinical practice, validation matters.

This Pathologist interview explores why rigorous validation, quality control, and clinical oversight are critical to delivering AI insights clinicians can trust.

Read more: buff.ly/Jg989KI

#DigitalPathology #ArteraAI

#ArteraAI